Format

Send to

Choose Destination
Semin Surg Oncol. 2003;21(3):164-75.

Extensive-stage small-cell lung cancer.

Author information

1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231-1000, USA. alexander.spira@usoncology.com

Abstract

Extensive-stage small-cell lung cancer (ES-SCLC) continues to be a difficult management issue. While response rates to therapy are relatively high, durable responses are rare, and long-term survival rates are dismal. Although many attempts have been made to develop new therapies, cisplatin-based combination chemotherapy remains the mainstay in the management of these patients. In this review we highlight recent developments in the treatment and management of this malignancy, and discuss future prospects in treatment.

PMID:
14508849
DOI:
10.1002/ssu.10034
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center